Table 1.
Patient Characteristics
| Characteristic | Methotrexate |
Dactinomycin |
||
|---|---|---|---|---|
| No. | % | No. | % | |
| Age group, years | ||||
| 10-19 | 14 | 13.1 | 10 | 9.2 |
| 20-29 | 52 | 48.6 | 45 | 41.3 |
| 30-39 | 31 | 29.0 | 41 | 37.6 |
| 40-49 | 7 | 6.5 | 11 | 10.1 |
| 50-59 | 3 | 2.8 | 2 | 1.8 |
| Ethnicity | ||||
| Hispanic or Latino | 12 | 11.2 | 14 | 12.8 |
| Non-Hispanic | 85 | 79.4 | 88 | 80.7 |
| Unknown/not specified | 10 | 9.3 | 7 | 6.4 |
| Race | ||||
| Unknown | 11 | 10.3 | 7 | 6.4 |
| Asian | 9 | 8.4 | 16 | 14.7 |
| American Indian/Alaskan native | 1 | 0.9 | 3 | 2.8 |
| Black/African American | 17 | 15.9 | 16 | 14.7 |
| White | 69 | 64.5 | 67 | 61.5 |
| Molar class | ||||
| Complete mole | 81 | 75.7 | 94 | 86.2 |
| Partial mole | 17 | 15.9 | 12 | 11.0 |
| Choriocarcinoma | 7 | 6.5 | 3 | 2.8 |
| Indeterminate/not specified | 1 | 1.9 | 0 | 0.0 |
| WHO score | ||||
| 0 | 14 | 13.1 | 13 | 11.9 |
| 1 | 40 | 37.4 | 38 | 34.9 |
| 2 | 20 | 18.7 | 30 | 27.5 |
| 3 | 15 | 14.0 | 14 | 12.8 |
| 4 | 10 | 9.3 | 5 | 4.6 |
| 5 | 4 | 3.7 | 5 | 4.6 |
| 6 | 4 | 3.7 | 4 | 3.7 |